Management of hyperglycemia during enteral and parenteral nutrition therapy.
Hyperglycemia is a frequent complication of enteral and parenteral nutrition in hospitalized patients. Extensive evidence from observational studies indicates that the development of hyperglycemia during parenteral and enteral nutrition is associated with an increased risk of death and infectious complications. There are no specific guidelines recommending glycemic targets and effective strategies for the management of hyperglycemia during specialized nutritional support. Managing hyperglycemia in these patients should include optimization of carbohydrate content and administration of intravenous or subcutaneous insulin therapy. The administration of continuous insulin infusion and insulin addition to nutrition bag are efficient approaches to control hyperglycemia during parenteral nutrition. Subcutaneous administration of long-acting insulin with scheduled or corrective doses of short-acting insulin is superior to the sliding scale insulin strategy in patients receiving enteral feedings. Randomized controlled studies are needed to evaluate safe and effective therapeutic strategies for the management of hyperglycemia in patients receiving nutritional support.
Department of Medicine, Division of Endocrinology, University of Tennessee Health Science Center, 920 Madison Avenue, Suite 300A, Memphis, TN 38163, USA. agosmano@uthsc.edu
Aidar R
AR
Gosmanov
Guillermo E
GE
Umpierrez
D004032:Diet; D004750:Enteral Nutrition / Q000009:adverse effects*; D006801:Humans; D006943:Hyperglycemia / Q000178:diet therapy / Q000188:drug therapy* / Q000209:etiology*; D007328:Insulin / Q000627:therapeutic use; D010288:Parenteral Nutrition / Q000009:adverse effects*
D007328:Insulin